MedicineInfectious DiseasesPharmacologyAntimicrobial PharmacologyAntimicrobial PharmacotherapyDiagnostic MicrobiologyAntibacterial AgentsAntibacterial PharmacologyMedicinal PlantsBotanical BioassaysConcentration-dependent ActivityHerbal Remedy PreparationLeaf Extract AssaysMinimum Inhibitory Concentration TestingPlant Extract InhibitorsStaphylococcus Aureus Control
The aim of this study is to determine the antibacterial activity of Piper betle L. leaf extract on inhibiting Staphylococcus aureus in conjunctivitis patient. This study follows a post-test only group experimental design. Antibacterial activities of five Piper betle L. extract concentrations (0.5%, 1%, 1.5%, 2%, 2.5%, and 3%) against Staphylococcus aureus were evaluated by agar well diffusion method. The negative control group (P-) was treated with standard 10% DMSO solution, the positive control group (P+) with ceftriaxone. The diameters of clear zone surrounding the well were analyzed with Kruskal-Wallis test and showed that in between 1% and 1.5%; 1.5% and 2%; 2% and 2.5%; 2.5% and 3% concentrations do not show a significant difference but in between 0.5% and 1%; 0.5% and 1.5%; 0.5% and 2%; 0.5% and 2.5%; 0.5% and 3%; 1% and 2%; 1% and 2.5%; 1% and 3%; 1.5% and 2.5%; 1.5% and 3%; 2% and 3% concentrations, Piper betle L. leaf extract shows a significant difference on inhibiting the growth of Staphylococcus aureus. In conclusion the results obtained show that that Piper betle L. leaf extract has a significant potential use as an antibacterial agent.
10
Somashekar Shetty, S. L. Udupa, Laxminarayana A Udupa · Evidence-based Complementary and Alternative Medicine · 2007 · 212 citations · Full text
Reversal of silver sulfadiazine-impaired wound healing by epidermal growth factor
Ae-Ri Cho Lee, Hyunju Leem, Jae-Gwan Lee et al. · Biomaterials · 2005 · 139 citations
Medicine, Dermatology, Pathology +9